BR112015000836A2 - método para identificar um polipeptídeo tendo uma funcionalidade ou especificidade de ligação desejadas, biblioteca de moléculas de polinucleotídeo, método para gerar uma biblioteca de polinucleotídeos, vetor, célula hospedeira, anticorpo e método para gerar uma população de células hospedeiras - Google Patents
método para identificar um polipeptídeo tendo uma funcionalidade ou especificidade de ligação desejadas, biblioteca de moléculas de polinucleotídeo, método para gerar uma biblioteca de polinucleotídeos, vetor, célula hospedeira, anticorpo e método para gerar uma população de células hospedeirasInfo
- Publication number
- BR112015000836A2 BR112015000836A2 BR112015000836A BR112015000836A BR112015000836A2 BR 112015000836 A2 BR112015000836 A2 BR 112015000836A2 BR 112015000836 A BR112015000836 A BR 112015000836A BR 112015000836 A BR112015000836 A BR 112015000836A BR 112015000836 A2 BR112015000836 A2 BR 112015000836A2
- Authority
- BR
- Brazil
- Prior art keywords
- generating
- library
- host cell
- transposition
- polynucleotide
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 8
- 102000040430 polynucleotide Human genes 0.000 title abstract 4
- 108091033319 polynucleotide Proteins 0.000 title abstract 4
- 239000002157 polynucleotide Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title abstract 3
- 230000017105 transposition Effects 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000012411 cloning technique Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 238000012163 sequencing technique Methods 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
- 230000010474 transient expression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
resumo método para identificar um polipeptídeo tendo uma funcionalidade ou especificidade de ligação desejadas, biblioteca de moléculas de polinucleotídeo, método para gerar uma biblioteca de polinucleotídeos, vetor, célula hospedeira, anticorpo e método para gerar uma população de células hospedeiras a presente invenção refere-se a um método que oferece eficiência, flexibilidade, utilidade e velocidade incomparáveis para a descoberta e otimização de polipeptídeos com funcionalidade e/ou especificidade de ligação desejadas, incluindo moléculas de ligação a antígeno, tais como anticorpos e fragmentos dos mesmos, para fenótipos funcionais e/ou de ligação desejados. o novo método baseia-se em construções de transposição e bibliotecas de adn diversificadas clonadas em vetores de transposição e em sua transfeção em células hospedeiras por expressão transitória concomitante de uma enzima transponase funcional. isto assegura uma introdução eficiente e estável de vetores de expressão baseados na transposição de células hospedeiras de vertebrados em uma etapa, que podem depois ser classificados em relação a um fenótipo funcional ou de ligação desejado das proteínas expressas, após o que as sequências codificantes relevantes para as proteínas expressas, incluindo anticorpos e fragmentos dos mesmos, podem ser identificadas por técnicas de clonagem e de sequenciação de adn convencionais. ?? ?? ?? ?? 1/1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261673144P | 2012-07-18 | 2012-07-18 | |
US61/673,144 | 2012-07-18 | ||
EP12178529.9A EP2692865B1 (en) | 2012-07-30 | 2012-07-30 | Transposition-mediated identification of specific binding or functional proteins |
EP12178529-9 | 2012-07-30 | ||
PCT/EP2013/065214 WO2014013026A1 (en) | 2012-07-18 | 2013-07-18 | Transposition-mediated identification of specific binding or functional proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015000836A2 true BR112015000836A2 (pt) | 2017-12-12 |
BR112015000836B1 BR112015000836B1 (pt) | 2021-12-21 |
Family
ID=49775745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015000836-4A BR112015000836B1 (pt) | 2012-07-18 | 2013-07-18 | Método para identificar um polipeptídeo tendo uma funcionalidade ou especificidade de ligação desejadas, biblioteca de moléculas de polinucleotídeo, método para gerar uma biblioteca de polinucleotídeos e método para gerar uma população de células hospedeiras |
Country Status (19)
Country | Link |
---|---|
US (2) | US10174309B2 (pt) |
EP (2) | EP2692865B1 (pt) |
JP (1) | JP6043431B2 (pt) |
CN (1) | CN104640985B (pt) |
AU (1) | AU2013291971B2 (pt) |
BR (1) | BR112015000836B1 (pt) |
CA (1) | CA2878982C (pt) |
DK (1) | DK2692865T3 (pt) |
ES (1) | ES2528892T3 (pt) |
HK (1) | HK1209779A1 (pt) |
IL (1) | IL236771A (pt) |
IN (1) | IN2015DN01301A (pt) |
MX (1) | MX338911B (pt) |
NZ (1) | NZ705074A (pt) |
PT (1) | PT2692865E (pt) |
SG (1) | SG11201500280XA (pt) |
SI (1) | SI2692865T1 (pt) |
WO (1) | WO2014013026A1 (pt) |
ZA (1) | ZA201500203B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201407852D0 (en) | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
WO2017072361A1 (en) | 2015-10-30 | 2017-05-04 | Nbe-Therapeutics Ag | Anti-ror1 antibodies |
EP3405496B1 (en) | 2016-01-20 | 2023-10-25 | University of Florida Research Foundation, Incorporated | Ror1 antibody compositions and related methods |
JP2019509023A (ja) | 2016-01-20 | 2019-04-04 | ザ・スクリップス・リサーチ・インスティテュート | Ror2抗体組成物及び関連する方法 |
IL299000A (en) * | 2016-04-04 | 2023-02-01 | Eth Zuerich | A mammalian cell line for protein production and a breeding library |
US11155574B2 (en) * | 2016-12-09 | 2021-10-26 | Gliknik Inc. | Manufacturing optimization of GL-2045, a multimerizing stradomer |
CN110022898B (zh) | 2016-12-09 | 2023-07-04 | 格利克尼克股份有限公司 | 用多价Fc化合物治疗炎性疾病的方法 |
CN110730821B (zh) | 2016-12-16 | 2023-12-08 | 比莫根生物科技公司 | 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法 |
US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
EP3655437A1 (en) | 2017-07-20 | 2020-05-27 | NBE-Therapeutics AG | Human antibodies binding to ror2 |
SG11202000846WA (en) | 2017-08-07 | 2020-02-27 | Nbe Therapeutics Ag | Anthracycline-based antibody drug conjugates having high in vivo tolerability |
EP3794128A1 (en) * | 2018-05-18 | 2021-03-24 | Sorbonne Universite | Molecular tools and methods for transgene integration and their transposition dependent expression |
US11760983B2 (en) | 2018-06-21 | 2023-09-19 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
JP7208380B2 (ja) * | 2018-10-26 | 2023-01-18 | エフ.ホフマン-ラ ロシュ アーゲー | リコンビナーゼ媒介性カセット交換を使用した多重特異性抗体スクリーニング法 |
JP2020146014A (ja) * | 2019-03-15 | 2020-09-17 | 株式会社東芝 | トランスポゼース活性測定用ベクター、トランスポゼース活性測定用キット、トランスポゼース活性測定方法及び細胞分離方法 |
GB2605276A (en) | 2019-09-03 | 2022-09-28 | Myeloid Therapeutics Inc | Methods and compositions for genomic integration |
CN111139264B (zh) * | 2020-01-20 | 2021-07-06 | 天津达济科技有限公司 | 一种基于线性双链dna分子在哺乳动物细胞系内构建单域抗体库的方法 |
CN111471714A (zh) * | 2020-05-07 | 2020-07-31 | 西南大学 | Minos转座子系统介导的真核生物转基因细胞系及构建方法 |
CN117396607A (zh) | 2020-12-30 | 2024-01-12 | 阿劳诺斯治疗公司 | 包含多顺反子表达盒的重组载体及其使用方法 |
JP2024507929A (ja) | 2021-02-25 | 2024-02-21 | アラウノス セラピューティクス インコーポレイテッド | 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 |
KR20230164128A (ko) * | 2021-03-31 | 2023-12-01 | 디디바이오. 코포레이션 엘티디.,(상하이) | 기능성 항원 결합 단백질 선별을 위한 벡터 및 방법 |
WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
WO2024102954A1 (en) | 2022-11-10 | 2024-05-16 | Massachusetts Institute Of Technology | Activation induced clipping system (aics) |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5667988A (en) * | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
US6218185B1 (en) | 1996-04-19 | 2001-04-17 | The United States Of America As Represented By The Secretary Of Agriculture | Piggybac transposon-based genetic transformation system for insects |
US6489458B2 (en) | 1997-03-11 | 2002-12-03 | Regents Of The University Of Minnesota | DNA-based transposon system for the introduction of nucleic acid into DNA of a cell |
US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
US7105343B1 (en) | 2000-10-31 | 2006-09-12 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector Piggybac |
US6962810B2 (en) | 2000-10-31 | 2005-11-08 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac |
CA2446453A1 (en) | 2001-06-14 | 2002-12-27 | Basf Corporation | Light-stabilized polymers comprising light-stabilizing moieties, articles therefrom and a method of making the same |
US8227432B2 (en) | 2002-04-22 | 2012-07-24 | Regents Of The University Of Minnesota | Transposon system and methods of use |
CA2489595C (en) * | 2002-06-14 | 2013-05-28 | Simon E. Hufton | Recombination of nucleic acid library members |
WO2004005322A2 (en) | 2002-07-10 | 2004-01-15 | Stratagene | Humanized renilla reniformis green fluorescent protein as a scaffold |
WO2004010957A2 (en) | 2002-07-31 | 2004-02-05 | Seattle Genetics, Inc. | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
WO2005062881A2 (en) * | 2003-12-24 | 2005-07-14 | Transgenrx, Inc. | Gene therapy using transposon-based vectors |
US7932088B1 (en) | 2005-04-25 | 2011-04-26 | University Of Notre Dame Du Lac | High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac |
US20060252140A1 (en) | 2005-04-29 | 2006-11-09 | Yant Stephen R | Development of a transposon system for site-specific DNA integration in mammalian cells |
EP1947180B1 (en) * | 2005-10-18 | 2012-12-05 | National Institute Of Agrobiological Sciences | Antibody producing transgenic silkworms and method for producing the same |
US20090042297A1 (en) * | 2007-06-01 | 2009-02-12 | George Jr Alfred L | Piggybac transposon-based vectors and methods of nucleic acid integration |
US9228180B2 (en) | 2007-07-04 | 2016-01-05 | Max-Delbruck-Centrum Fur Molekulare Medizin | Polypeptide variants of sleeping beauty transposase |
AU2008302397A1 (en) | 2007-09-17 | 2009-03-26 | Affomix Corporation | Increasing specificity in a scFv screen using dual bait reporters |
US7863425B2 (en) * | 2007-09-26 | 2011-01-04 | Cornell University | Compositions and methods for inhibiting Yersinia pestis infection |
US7968687B2 (en) | 2007-10-19 | 2011-06-28 | Seattle Genetics, Inc. | CD19 binding agents and uses thereof |
EP2235181A1 (en) | 2008-01-11 | 2010-10-06 | MorphoSys AG | Display vectors and methods and uses thereof |
US9131671B2 (en) * | 2008-02-01 | 2015-09-15 | Entogenetics, Inc. | Methods, compositions and systems for production of recombinant spider silk polypeptides |
JP2009225781A (ja) * | 2008-02-29 | 2009-10-08 | Neosilk Co Ltd | カイコを用いた糖鎖構造に特徴を有する糖蛋白質の製造方法 |
EP2098536A1 (en) * | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
US20110275535A1 (en) | 2008-12-16 | 2011-11-10 | Novartis Ag | Yeast Display Systems |
US20100311116A1 (en) * | 2009-06-04 | 2010-12-09 | Excellgene Sa | Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressure |
SG10201602874VA (en) | 2010-12-15 | 2016-05-30 | Kek High Energy Accelerator | Protein production method |
-
2012
- 2012-07-30 ES ES12178529.9T patent/ES2528892T3/es active Active
- 2012-07-30 PT PT121785299T patent/PT2692865E/pt unknown
- 2012-07-30 DK DK12178529.9T patent/DK2692865T3/en active
- 2012-07-30 EP EP12178529.9A patent/EP2692865B1/en active Active
- 2012-07-30 SI SI201230139T patent/SI2692865T1/sl unknown
-
2013
- 2013-07-18 AU AU2013291971A patent/AU2013291971B2/en active Active
- 2013-07-18 US US14/414,981 patent/US10174309B2/en active Active
- 2013-07-18 WO PCT/EP2013/065214 patent/WO2014013026A1/en active Application Filing
- 2013-07-18 NZ NZ705074A patent/NZ705074A/en unknown
- 2013-07-18 SG SG11201500280XA patent/SG11201500280XA/en unknown
- 2013-07-18 MX MX2015000885A patent/MX338911B/es active IP Right Grant
- 2013-07-18 CN CN201380048308.7A patent/CN104640985B/zh active Active
- 2013-07-18 CA CA2878982A patent/CA2878982C/en active Active
- 2013-07-18 BR BR112015000836-4A patent/BR112015000836B1/pt active IP Right Grant
- 2013-07-18 EP EP13177083.6A patent/EP2687599A1/en not_active Withdrawn
- 2013-07-18 JP JP2015522101A patent/JP6043431B2/ja active Active
-
2015
- 2015-01-13 ZA ZA2015/00203A patent/ZA201500203B/en unknown
- 2015-01-18 IL IL236771A patent/IL236771A/en active IP Right Grant
- 2015-02-17 IN IN1301DEN2015 patent/IN2015DN01301A/en unknown
- 2015-09-08 HK HK15108709.8A patent/HK1209779A1/xx unknown
-
2018
- 2018-10-30 US US16/175,073 patent/US20190153433A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2015522286A (ja) | 2015-08-06 |
EP2692865A1 (en) | 2014-02-05 |
CN104640985A (zh) | 2015-05-20 |
PT2692865E (pt) | 2015-02-06 |
IN2015DN01301A (pt) | 2015-07-03 |
MX2015000885A (es) | 2015-07-14 |
EP2687599A1 (en) | 2014-01-22 |
EP2692865B1 (en) | 2014-12-10 |
CA2878982A1 (en) | 2014-01-23 |
AU2013291971A1 (en) | 2015-02-05 |
MX338911B (es) | 2016-05-05 |
US20190153433A1 (en) | 2019-05-23 |
DK2692865T3 (en) | 2015-02-16 |
ES2528892T3 (es) | 2015-02-13 |
NZ705074A (en) | 2017-04-28 |
WO2014013026A8 (en) | 2014-12-04 |
IL236771A (en) | 2016-09-29 |
US10174309B2 (en) | 2019-01-08 |
CA2878982C (en) | 2017-01-03 |
SG11201500280XA (en) | 2015-02-27 |
JP6043431B2 (ja) | 2016-12-14 |
US20150152406A1 (en) | 2015-06-04 |
WO2014013026A1 (en) | 2014-01-23 |
SI2692865T1 (sl) | 2015-03-31 |
BR112015000836B1 (pt) | 2021-12-21 |
CN104640985B (zh) | 2021-05-11 |
AU2013291971B2 (en) | 2016-02-04 |
ZA201500203B (en) | 2015-12-23 |
HK1209779A1 (en) | 2016-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015000836A2 (pt) | método para identificar um polipeptídeo tendo uma funcionalidade ou especificidade de ligação desejadas, biblioteca de moléculas de polinucleotídeo, método para gerar uma biblioteca de polinucleotídeos, vetor, célula hospedeira, anticorpo e método para gerar uma população de células hospedeiras | |
Perino et al. | MTF2 recruits Polycomb Repressive Complex 2 by helical-shape-selective DNA binding | |
Jenjaroenpun et al. | Decoding the epitranscriptional landscape from native RNA sequences | |
Kretschmer et al. | The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′–3′ exoribonuclease XRN1 | |
Eraslan et al. | Quantification and discovery of sequence determinants of protein‐per‐mRNA amount in 29 human tissues | |
Rossbach et al. | Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L | |
Zhao et al. | Massively parallel functional annotation of 3′ untranslated regions | |
Pasini et al. | JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells | |
White | Understanding how cis-regulatory function is encoded in DNA sequence using massively parallel reporter assays and designed sequences | |
EA201990861A1 (ru) | Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения | |
BR112019000512A2 (pt) | anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, composição, métodos de tratamento de uma doença, para produzir um anticorpo biespecífico e para detectar se a reticulação entre as células que expressam cd40 e cd137 ocorre em uma amostra, uso de um anticorpo multiespecífico, e, kit | |
BR112022021789A2 (pt) | Bibliotecas de ácido nucléico variantes para coronavírus | |
Cao et al. | Enhanced detection of post-transcriptional modifications using a mass-exclusion list strategy for RNA modification mapping by LC-MS/MS | |
Maruyama et al. | Histone and TK0471/TrmBL2 form a novel heterogeneous genome architecture in the hyperthermophilic archaeon Thermococcus kodakarensis | |
Luo et al. | The conserved intronic cleavage and polyadenylation site of CstF-77 gene imparts control of 3′ end processing activity through feedback autoregulation and by U1 snRNP | |
MX2019002498A (es) | Metodos y productos para la expresion de proteinas en celulas. | |
Kochetov et al. | uORFs, reinitiation and alternative translation start sites in human mRNAs | |
Wen et al. | The diversity of Shine-Dalgarno sequences sheds light on the evolution of translation initiation | |
BR112022002695A2 (pt) | Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso | |
Soldi et al. | Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers | |
MX2019009045A (es) | Nuevas luciferasas y metodos para su uso. | |
Krepelova et al. | Myc and max genome-wide binding sites analysis links the Myc regulatory network with the polycomb and the core pluripotency networks in mouse embryonic stem cells | |
Duan et al. | Fine-tuning multi-gene clusters via well-characterized gene expression regulatory elements: case study of the arginine synthesis pathway in C. glutamicum | |
BR112012012911A8 (pt) | métodos para triar uma molécula capaz de ligação a cd4, para produzir uma composição terapêutica, para triar um anticorpo ou fragmento de anticorpo capaz de ligar cd4, para a produção de um anticorpo ou fragmento de anticorpo in vitro para a ativação de células t regulatórias cd4+cd25+, para tratar um indivíduo, e para triar a presença de células regulatórias t cd4+cd25+ em uma amostra, composição terapêutica, anticorpo ou fragmento de anticorpo, peptídeo isolado, mimótopo de um peptídeo isolado, ácido nucleico, vetor, célula hospedeira ou hibridoma, usos de um anticorpo ou fragmento de anticorpo, do peptídeo isolado e de uma célula t regulatória cd4+cd25+, célula t regulatória cd4+cd25+, e, kit. | |
Tsitsipatis et al. | Practical guide for circular RNA analysis: Steps, tips, and resources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority | ||
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/07/2013, OBSERVADAS AS CONDICOES LEGAIS. |